
Avandia is a drug developed by GlaxoSmithKline for people suffering from type 2 diabetes mellitus. Type 2 diabetes is also referred to as “adult-onset” diabetes and “non-insulin dependent” diabetes. It is caused when a person’s body does not make enough insulin, or when their body cannot respond appropriately to its insulin production.
Avandia treatment is intended to lower blood sugar when used in conjunction with an appropriate diet and exercise. Avandia can also be used in association with other diabetes drugs to best target the condition and its effects. Avandia is taken in tablet form in a starting dose of 4mg (once a day) or 2mg (twice a day). While it has been found to aid in the treatment of type 2 diabetes, it has been associated with certain side effects, notably the issue of increased incidence of bone fracture in female patients.
Although Avandia has proven to be an effective mode of treatment of people suffering from type 2 diabetes mellitus, it has also been linked with the development of some serious side effects. Recent studies have linked Avandia with serious cardiovascular problems including heart attack and cardiovascular death. Women taking Avandia may face an increased risk of bone fracture.
Patients taking Avandia may also be at risk of developing a cardiovascular disease called primary pulmonary hypertension (PPH). While PPH is most commonly associated with a higher-than normal blood pressure in the pulmonary artery, it has also been shown to be associated with the development of heart valve disease and/or heart valve defects. Avandia patients who develop PPH may be entitled to receive compensation.
The controversy surrounding popular diabetes drug Avandia continues to grow as new information comes out regarding GlaxoSmithKline’s knowledge of Avandia heart risk.
A June 6, 2007 congressional hearing in Washington yielded damning information from a medical expert who testified that he approached the pharmaceutical company in 1999 with information related to Avandia heart risk. His testimony detailed legal threats issued by GlaxoSmithKline executives (then SmithKline Beecham) if he were to make noise regarding the serious cardiovascular side effects associated with the diabetes drug. On June 7, 2007, the Food and Drug Administration took action against GlaxoSmithKline by requiring a “black box” warning for Avandia that would alert consumers to the cardiovascular risk. “Black box” warnings are the most serious required by the FDA, and one-step closer to recall.
In addition to Avandia, the FDA will also require that Takeda Pharmaceuticals’ Actos include the same “black box” warning.
If you or a loved one has been injured as a result of using GlaxoSmithKline’s Avandia, you may be eligible to receive compensation for your pain, suffering, medical bills, etc. GlaxoSmithKline is in the process of running extensive tests geared towards determining the exact nature of the association between long-term Avandia treatment and an increased incidence of bone fractures in female patients.
The law offices of Justice Lawyers boast some of the most experienced personal injury lawyers Pensacola, Florida has to offer. The lawyers and staff representing Justice Lawyers are adept at dealing with a wide variety of injuries caused by various product defects and manufacturer negligence. Contact Justice Lawyers today at (850) 916 7450 to get additional information regarding your rights and as an Avandia injury victim.
The attorneys of the Law Office of Justice Lawyers are personal injury lawyers in Pensacola who protect victims of auto accidents, personal injury, wrongful death, defective drugs, consumer fraud, insurance fraud, product defects and defective medical devices, such as Guidant and Medtronic Pacemakers, and potentially harmful drugs, such as Ortho Evra. When you think of the top personal injury lawyers or car accident lawyers in Pensacola, think of Justice Lawyers.